STOK
Stoke Therapeutics, Inc. · Healthcare · Market cap $1.7B
Insiders sold $1.3M net in the last 90 days ·3 sellers, 0 buyers· 5 of 8 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.9M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 2, 2026
Ticho Barry
Stoke Therapeutics, Inc. (STOK) has 38 SEC Form 4 filings (105 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 8 insiders at Stoke Therapeutics, Inc. reported no open-market purchases and 43 open-market sales totaling $8.9M. The most active filer is CHIEF MEDICAL OFFICER Ticho Barry with 16 filings. Insiders have net sold $1.5M over the trailing 6 months. The most recent open-market filing is a sale of 1,051 shares by CHIEF MEDICAL OFFICER Ticho Barry, dated Oct 1, 2026, worth $27K.
- Industry:Biotechnology
- CEO:Ian F. Smith
- Employees:170
- HQ:Bedford, MA, US
- IPO:2019-06-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CHIEF MEDICAL OFFICER | Sale | 1,051 | $27K | Oct 2 | +0.2% | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 627 | $17K | Oct 2 | +0.2% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,545 | $170K | Sep 3 | -14.4% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 4,767 | $153K | Aug 19 | -22.3% | SEC ↗ | |
| Director | Sale | 12,567 | $403K | Aug 19 | -22.3% | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 2,861 | $92K | Aug 19 | -22.3% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 7,176 | $208K | Aug 5 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 7,228 | $236K | Jul 6 | — | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $44K | Jun 18 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 1,795 | $55K | Jun 3 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 2,243 | $74K | May 5 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 1,838 | $60K | Apr 3 | — | SEC ↗ | |
| GENERAL COUNSEL & CORP SEC | Sale | 9,293 | $313K | Mar 24 | — | SEC ↗ | |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,164 | $203K | Mar 19 | — | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,686 | $210K | Mar 19 | — | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 1,461 | $44K | Mar 19 | — | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,196 | $72K | Mar 19 | — | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,382 | $75K | Mar 19 | — | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,781 | $59K | Mar 19 | — | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,931 | $61K | Mar 19 | — | SEC ↗ |
Allan JonathanFirst in 3 months | GENERAL COUNSEL & CORP SEC | Sale | 4,267 | $141K | Mar 19 | — | SEC ↗ |
Allan JonathanFirst in 3 months | GENERAL COUNSEL & CORP SEC | Sale | 4,628 | $145K | Mar 19 | — | SEC ↗ |
| Director | Sale | 605 | $22K | Mar 17 | — | SEC ↗ | |
TZIANABOS ARTHURFirst filing | Interim Executive Chair | Sale | 4,355 | $174K | Mar 12 | — | SEC ↗ |
| Director | Sale | 33,243 | $1.3M | Mar 12 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does STOK have?
Stoke Therapeutics, Inc. (STOK) has 38 SEC Form 4 filings (105 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for STOK?
The most recent Form 4 filing for STOK on Tracefour is dated Oct 2, 2026.
Who is the most active insider at STOK?
The most active SEC Form 4 filer at STOK in the rolling window is CHIEF MEDICAL OFFICER Ticho Barry, with 16 filings.
What is the net insider flow at STOK over the last 6 months?
Over the trailing 180 days, insiders at STOK have net sold $1.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at STOK in the current window?
Inside the rolling window, insiders at STOK bought $0 and sold $8.9M based on SEC Form 4 filings.
Can I get alerts for STOK insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Stoke Therapeutics, Inc. (STOK). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Stoke Therapeutics, Inc. is in the Healthcare sector.